Results 131 to 140 of about 4,117 (197)

Shared Mechanistic Pathways in Bullous Pemphigoid, Chronic Spontaneous Urticaria, Prurigo Nodularis, and Chronic Prurigo of Unknown Origin: Implications for Targeted Therapies. [PDF]

Am J Clin Dermatol
Schmidt E, Puga MF, Kim BS, Simpson EL.
europepmc   +1 more source

Acute T-cell leukemia/lymphoma presenting with leukemia cutis mimicking prurigo nodularis. [PDF]

JAAD Case Rep
Elghannam M, Osto M, Strong J, Driscoll M.   +3 more
europepmc   +1 more source

Vixarelimab in Patients With Prurigo Nodularis: A Randomized Clinical Trial.

JAMA Dermatol
Ständer S, Yosipovitch G, Sofen H, Abramzon D, Galanter J, Wang S, Paolini JF.   +6 more
europepmc   +1 more source

Efficacy and Safety of Conventional and Biologic Therapies in Prurigo Nodularis: A Systematic Review and Meta-Analysis. [PDF]

Int J Dermatol
Lancz A, Meznerics FA, Árok R, Lengyel AS, Szabó B, Hegyi P, Kiss N, Bánvölgyi A.   +7 more
europepmc   +1 more source

Prurigo nodularis en plaque resolved after a loading dose of nemolizumab. [PDF]

Proc (Bayl Univ Med Cent)
Cho SW, Chen H, Chen A, Sontam T, Tarbox M.   +4 more
europepmc   +1 more source

Rapid itch relief with the biologic agent nemolizumab in Atopic dermatitis and Prurigo nodularis: Promise, complexity and clinical implications. [PDF]

J Eur Acad Dermatol Venereol
Lukaschek K, Weisshaar E.
europepmc   +1 more source

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis. [PDF]

J Eur Acad Dermatol Venereol
Legat FJ, Kwatra SG, Reich A, Boulinguez S, Tsianakas A, Sauder M, Barbarot S, Szepietowski JC, Conrad C, Pink AE, Weisshaar E, Misery L, Metz M, Laquer VT, Sivamani RK, Yosipovitch G, Thaçi D, Skov L, Chen X, Noda A, Jabbar-Lopez ZK, Piketty C, Ständer S.   +22 more
europepmc   +1 more source

A Conceptual Disease Model of Symptoms and Impacts in Adults with Prurigo Nodularis: A Qualitative and Literature-Informed Study. [PDF]

Dermatol Ther (Heidelb)
Kwatra SG, Rodriguez D, Dias-Barbosa C, Piketty C, Rout R, Subramanian R, Puelles J.   +6 more
europepmc   +1 more source

Dupilumab in moderate-to-severe prurigo nodularis: Real-world data from early access program. [PDF]

J Eur Acad Dermatol Venereol
Jachiet M, Toussaint C, Dorizy-Vuong V, Osdoit S, Becherel PA, Amazan E, Vanlerberghe J, Samimi M, Soares Barbosa C, Vera C, Wiggins S, Marcadé Fulcrand V, Meyer C, Misery L, Bouaziz JD.   +14 more
europepmc   +1 more source

Comprehensive Transcriptomic Profiling of Nonatopic Prurigo Nodularis in Korean Patients Reveals Il-22-driven Epidermal Stress and Neuro-immuno-fibrotic Remodelling. [PDF]

Acta Derm Venereol
Kim HS, Kim YS, Yosipovitch G.
europepmc   +1 more source